ES2060329T3 - Emulsion que contiene calcitonina, para administracion nasal. - Google Patents

Emulsion que contiene calcitonina, para administracion nasal.

Info

Publication number
ES2060329T3
ES2060329T3 ES91402231T ES91402231T ES2060329T3 ES 2060329 T3 ES2060329 T3 ES 2060329T3 ES 91402231 T ES91402231 T ES 91402231T ES 91402231 T ES91402231 T ES 91402231T ES 2060329 T3 ES2060329 T3 ES 2060329T3
Authority
ES
Spain
Prior art keywords
nasal administration
calcitonine
emulsion containing
calcitonin
preparations
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES91402231T
Other languages
English (en)
Inventor
Nakayuki Yamamoto
Michihiko Sugimoto
Hideo Sakakibara
Masaru Saita
Yuji Shimozono
Takafumi Manako
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Asahi Kasei Corp
Hisamitsu Pharmaceutical Co Inc
Asahi Chemical Industry Co Ltd
Original Assignee
Hisamitsu Pharmaceutical Co Inc
Asahi Chemical Industry Co Ltd
Asahi Kasei Kogyo KK
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hisamitsu Pharmaceutical Co Inc, Asahi Chemical Industry Co Ltd, Asahi Kasei Kogyo KK filed Critical Hisamitsu Pharmaceutical Co Inc
Application granted granted Critical
Publication of ES2060329T3 publication Critical patent/ES2060329T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/23—Calcitonins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Endocrinology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Biophysics (AREA)
  • Otolaryngology (AREA)
  • Molecular Biology (AREA)
  • Dispersion Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Organic Chemistry (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)

Abstract

LA PRESENTE INVENCION SE REFIERE A PREPARACIONES DE EMULSION PARA ADMINISTRACION NASAL QUE CONTIENEN CALCITIONINAS, QUE SE ADMINISTRAN SEGURA Y EFICAZMENTE, COMPARADA CON LAS PREPARACIONES DE CALCITIONINA CONVENCIONAL. LAS EMULSIONES SE PREPARAN UTILIZANDO UNA CALCIOTININA COMO INGREDIENTE ACTIVO, UN DERIVADO DE AZACICLOALCANO COMO EL PROMOTOR DE ABSORCION COMO LA 1 ZICO O SU SAL.
ES91402231T 1990-08-16 1991-08-12 Emulsion que contiene calcitonina, para administracion nasal. Expired - Lifetime ES2060329T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2215044A JPH078806B2 (ja) 1990-08-16 1990-08-16 カルシトニン類含有経鼻投与用乳剤

Publications (1)

Publication Number Publication Date
ES2060329T3 true ES2060329T3 (es) 1994-11-16

Family

ID=16665828

Family Applications (1)

Application Number Title Priority Date Filing Date
ES91402231T Expired - Lifetime ES2060329T3 (es) 1990-08-16 1991-08-12 Emulsion que contiene calcitonina, para administracion nasal.

Country Status (13)

Country Link
US (1) US5281580A (es)
EP (1) EP0471618B1 (es)
JP (1) JPH078806B2 (es)
KR (1) KR950000770B1 (es)
AT (1) ATE95063T1 (es)
AU (1) AU629758B2 (es)
CA (1) CA2047903C (es)
DE (1) DE69100436T2 (es)
DK (1) DK0471618T3 (es)
ES (1) ES2060329T3 (es)
IE (1) IE65630B1 (es)
NZ (1) NZ239166A (es)
PT (1) PT98692B (es)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3090353B2 (ja) * 1991-09-17 2000-09-18 旭化成工業株式会社 パラチロイドホルモン類含有経鼻投与用乳剤
IT1251685B (it) * 1991-10-11 1995-05-19 Isf Spa Composizioni farmaceutiche contenenti una calcitonina
CA2160681A1 (en) * 1993-04-19 1994-10-27 Masao Takahashi Microemulsion preparation containing a slightly absorbable substance
EP0726075A1 (en) * 1995-02-08 1996-08-14 Therapicon Srl Pharmaceutical non-inorganic saline solutions for endonasal administration
DE29723959U1 (de) * 1997-07-22 1999-07-22 Zellner, Gerhard, Dr., 83435 Bad Reichenhall Nasenspray-Flüssigkeit
TWI243687B (en) * 1998-04-21 2005-11-21 Teijin Ltd Pharmaceutical composition for application to mucosa
JP2000247911A (ja) * 1999-02-26 2000-09-12 Hisamitsu Pharmaceut Co Inc 大腸用吸収促進剤
AR026073A1 (es) 1999-10-20 2002-12-26 Nycomed Gmbh Composicion farmaceutica acuosa que contiene ciclesonida
AU783952B2 (en) 2000-02-04 2006-01-05 Unigene Laboratories, Inc. Nasal calcitonin formulations
US7244703B2 (en) * 2001-06-22 2007-07-17 Bentley Pharmaceuticals, Inc. Pharmaceutical compositions and methods for peptide treatment
WO2004084859A2 (en) * 2003-03-21 2004-10-07 Nastech Pharmaceutical Company Inc. Nasal calcitonin formulations containing chlorobutanol
CN101829319A (zh) 2003-12-08 2010-09-15 Cpex药品公司 用于胰岛素治疗的药用组合物及方法
GB2423711B (en) * 2005-10-24 2007-02-14 Fortune Apex Dev Ltd Method for preparing a pharmaceutical composition with enhanced mucoadhesion
WO2008007214A2 (en) * 2006-07-07 2008-01-17 Avestha Gengraine Technologies Pvt. Ltd. Glycyrrhiza glabra plant extracts for treating osteoporosis and the extraction process thereof
CN102727870B (zh) 2006-09-27 2014-04-30 旭化成制药株式会社 鲑降钙素的应用
KR101686271B1 (ko) 2009-11-18 2016-12-13 아사히 가세이 파마 가부시키가이샤 인간 변형성 슬관절증의 예방제 및/또는 치료제 및/또는 악화 억제제
US20190210394A1 (en) * 2018-01-05 2019-07-11 Beatrice A. Darby Reading staff book system

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2212062A (en) * 1938-04-16 1940-08-20 Harry O Duerr Waste destructor and garbage reclamation unit
GB2127689B (en) * 1982-10-05 1986-07-09 Sandoz Ltd Calcitonin inhalation compositions
AU572815B2 (en) * 1982-12-29 1988-05-19 Armour Pharmaceutical Company Pharmaceutical calcitonin compositions for intranasal application
JPS61267528A (ja) * 1984-11-26 1986-11-27 Yamanouchi Pharmaceut Co Ltd 吸収促進剤を含有するカルシトニン経鼻剤
US4690852A (en) * 1985-06-11 1987-09-01 Paul Gach Foil for stained glass assembly
EP0234745B1 (en) * 1986-01-29 1991-06-12 Dyson Refractories Limited Catalysts
JPH0643390B2 (ja) * 1986-04-08 1994-06-08 久光製薬株式会社 アザシクロアルカン誘導体
ES2061688T3 (es) * 1987-11-13 1994-12-16 Smithkline Beecham Farma Composiciones farmaceuticas que comprenden una calcitonina y un glicirricinato como mejorador de la absorcion.
US5026825A (en) * 1988-09-08 1991-06-25 Rhone-Poulenc Rorer Pharmaceuticals Inc. Intranasal calcitonin formulations
JPH0669956B2 (ja) * 1988-09-30 1994-09-07 旭化成工業株式会社 ポリペプタイド類の吸着防止剤

Also Published As

Publication number Publication date
KR950000770B1 (ko) 1995-02-02
DE69100436D1 (de) 1993-11-04
DE69100436T2 (de) 1994-01-20
IE912614A1 (en) 1992-02-26
JPH0499729A (ja) 1992-03-31
NZ239166A (en) 1992-11-25
CA2047903C (en) 1995-12-05
PT98692A (pt) 1992-07-31
AU629758B2 (en) 1992-10-08
CA2047903A1 (en) 1992-02-17
KR920003991A (ko) 1992-03-27
IE65630B1 (en) 1995-11-01
PT98692B (pt) 1999-01-29
AU8244591A (en) 1992-02-20
DK0471618T3 (da) 1993-11-29
ATE95063T1 (de) 1993-10-15
EP0471618A1 (en) 1992-02-19
EP0471618B1 (en) 1993-09-29
US5281580A (en) 1994-01-25
JPH078806B2 (ja) 1995-02-01

Similar Documents

Publication Publication Date Title
ES2060329T3 (es) Emulsion que contiene calcitonina, para administracion nasal.
DK0552256T3 (da) Fremgangsmåde til at behandle eller forebygge type 1 diabetes ved peroral indgivelse af insulin
ES2061252T3 (es) Agente antitusivo y regulador de la mucosa, procedimiento para su preparacion y composiciones farmaceuticas que lo contienen.
KR890003369A (ko) 약제학적 제제
DK358384A (da) Farmaceutiske midler til bekaempelse af diabetes mellitus
DE69127470D1 (de) Verstärkung der unterdrückungsregulation von autoimmunkrankheiten durch orale oder enterale verabreichung von autoantigenen
DK0427247T3 (da) Lægemiddel indeholdende R-alpha- lipoinsyre eller S-alphalipoinsyre som aktiv bestanddel
PT83647B (pt) Processo para a preparacao de novos derivados de benzimidazole com actividade farmacologica e de composicoes farmaceuticas que os contem
ES2171469T3 (es) Composicion administrada por via nasal y preparacion que la contiene.
ATE110931T1 (de) Insektizides produkt.
NO872880L (no) FremgangsmŸte for fremstilling av difenylpropylamin-derivater.
DE69226370D1 (de) Parathyroidhormon enthaltene emulsion zur nasalen verabreichung
PT92647A (pt) Processo para a preparacao de 5-cloro-2-< { (3,4-dimetoxi-2-piridinil)-metil}-sulfinil>-1h-benzimidazol e de composicoes farmaceuticas que o contem
DE69333723D1 (de) Pharmazeutische zubereitung auf der basis von rhamnolipid gegen dermatologische erkrankungen
ES2103116T3 (es) Nuevos compuestos bi-aromaticos derivados de amida, composiciones farmaceuticas y cosmeticas que los contienen y utilizaciones.
PT82512B (pt) Processo para a preparacao de derivados de quinolilglicinamidas com actividade psicotropica e de composicoes farmaceuticas que os contem
DK178883D0 (da) 2-(2'-hydroxy-3'-(1,1-dimethylpropylamino)-propoxy)-beta-phenylpropiophenon, syreadditionssalte deraf, fremgangsmade til fremstilling deraf samt farmaceutiske praeparater med indhold deraf
LV10267A (lv) Savienojums arstniecibas lidzeklis panemiens savienojuma iegusanai
ATE82850T1 (de) Verwendung von 2-pyrimidinyl-1-piperazinderivaten.
ATE17576T1 (de) 4-phenyl-quinazolin-derivate wirksam auf das zentralnervensystem.
EA199800177A1 (ru) Способ снижения количества экзогенного инсулина, вводимого пациенту с инсулиннезависимым сахарным диабетом
SE8204670L (sv) Ny forening med antiulcerogen aktivitet, forfarande for dess framstellning och farmaceutisk beredning innehallande densamma
KR900014308A (ko) 비스펜에탄올아민
KR920019349A (ko) 불안을 치료하기 위한 r(+)-3-아미노-1-하이드록시-피롤리딘-2-온의 용도
DK0410876T3 (da) Anvendelse af glufosinat eller et salt deraf til fremstilling af insekticide præparater

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 471618

Country of ref document: ES